NCT00785551View on ClinicalTrials.gov

Comparative Study of Quinine Sulfate in Healthy Patients and in Patients With Renal Impairment

PHASE1TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
HealthyRenal Impairment
Interventions
DRUG

quinine sulfate

2 x 324mg given in one dose to healthy subjects

DRUG

quinine sulfate

2 x 324mg given as one dose to subjects with mild renal impairment

DRUG

quinine sulfate

2 x 324mg given as one dose to subjects with moderate renal impairment

Trial Locations (1)

33169

Cetero Research, Miami Gardens

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY